Your browser doesn't support javascript.
loading
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.
Kiluk, Brian D; Kleykamp, Bethea A; Comer, Sandra D; Griffiths, Roland R; Huhn, Andrew S; Johnson, Matthew W; Kampman, Kyle M; Pravetoni, Marco; Preston, Kenzie L; Vandrey, Ryan; Bergeria, Cecilia L; Bogenschutz, Michael P; Brown, Randall T; Dunn, Kelly E; Dworkin, Robert H; Finan, Patrick H; Hendricks, Peter S; Houtsmuller, Elisabeth J; Kosten, Thomas R; Lee, Dustin C; Levin, Frances R; McRae-Clark, Aimee; Raison, Charles L; Rasmussen, Kurt; Turk, Dennis C; Weiss, Roger D; Strain, Eric C.
Afiliação
  • Kiluk BD; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
  • Kleykamp BA; University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Comer SD; Division on Substance Use Disorders, New York State Psychiatric Institute, New York.
  • Griffiths RR; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.
  • Huhn AS; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Johnson MW; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Kampman KM; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Pravetoni M; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Preston KL; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Harborview Medical Center, Seattle.
  • Vandrey R; Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
  • Bergeria CL; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Bogenschutz MP; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Brown RT; Department of Psychiatry, NYU Grossman School of Medicine, New York University, New York.
  • Dunn KE; Department of Family Medicine and Community Health, University of Wisconsin-Madison School of Medicine and Public Health, Madison.
  • Dworkin RH; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Finan PH; University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Hendricks PS; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Houtsmuller EJ; Department of Health Behavior, School of Public Health, University of Alabama at Birmingham.
  • Kosten TR; Patient-Centered Outcomes Research Institute, Washington, DC.
  • Lee DC; Baylor College of Medicine, Houston, Texas.
  • Levin FR; Michael E. DeBakey VA Medical Center, Houston, Texas.
  • McRae-Clark A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Raison CL; Division on Substance Use Disorders, New York State Psychiatric Institute, New York.
  • Rasmussen K; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York.
  • Turk DC; Department of Psychiatry, Medical University of South Carolina, Charleston.
  • Weiss RD; Department of Human Development and Family Studies, School of Human Ecology, University of Wisconsin-Madison.
  • Strain EC; Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison.
JAMA Psychiatry ; 80(1): 84-92, 2023 01 01.
Article em En | MEDLINE | ID: mdl-36449315

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: JAMA Psychiatry Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: JAMA Psychiatry Ano de publicação: 2023 Tipo de documento: Article